Dianthus Therapeutics, Inc. (DNTH)
50.75
+4.17
(+8.95%)
USD |
NASDAQ |
Feb 06, 16:00
50.71
-0.04
(-0.08%)
After-Hours: 20:00
Dianthus Therapeutics Market Cap : 2.176B for Feb. 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cartesian Therapeutics, Inc. | 168.76M |
| Royalty Pharma Plc | 19.08B |
| ACADIA Pharmaceuticals, Inc. | 3.986B |
| Agenus, Inc. | 99.98M |
| Alnylam Pharmaceuticals, Inc. | 43.35B |
Market Cap Related Metrics
| PS Ratio | 595.38 |
| PEG Ratio | -0.3654 |
| Price to Book Value | 3.982 |
| Price | 50.75 |
| Earnings Yield | -6.88% |
| PEGY Ratio | -0.3654 |